3-(Trifluoromethyl)-5,6,7,8-Tetrahydro-[1.2,4]Triazolo[4,3-alpyrazine Hydrochloride

Products

Information

CAS: 762240-92-6 Sitagliptin intermediate An oral medication used in the treatment of diabetes

Taizhou Dachen Pharmaceuticals Co. LtdEstablished in 2017, Taizhou Dachen Pharmaceutical was designed and built to meet GMP guidelines, integrating research development and production of APIs and intermediates. The gross value of annual output is about 400 million yuan. As the National High-Tech Enterprise, the company's key products are predominantly demanded in Europe, Southeast Asia, South America, etc.

Log in

See all the content and easy-to-use features by logging in or registering!